Effects of glucagon-like peptide-I on glucose turnover in rats.

about

Pleiotropic effects of incretins GLP-1 receptor antagonist exendin-(9-39) elevates fasting blood glucose levels in congenital hyperinsulinism owing to inactivating mutations in the ATP-sensitive K+ channel Incretin-based therapies: new treatments for type 2 diabetes in the new millennium.

P2860

Q35968092-D3B263AC-7859-472C-905F-8F2A15C3AA7D Q36249759-29B912F8-11D6-40C5-81FB-906A1452687F Q37316259-8DE55091-F934-40E4-971D-82D710254733

P2860

Effects of glucagon-like peptide-I on glucose turnover in rats.

Item

http://www.wikidata.org/entity/Q51581175

description

1996 nî lūn-bûn

@nan

1996年の論文

@ja

1996年学术文章

@wuu

1996年学术文章

@zh

1996年学术文章

@zh-cn

1996年学术文章

@zh-hans

1996年学术文章

@zh-my

1996年学术文章

@zh-sg

1996年學術文章

@yue

1996年學術文章

@zh-hant

name

Effects of glucagon-like peptide-I on glucose turnover in rats.

@en

Effects of glucagon-like peptide-I on glucose turnover in rats.

@nl

type

Item

label

Effects of glucagon-like peptide-I on glucose turnover in rats.

@en

Effects of glucagon-like peptide-I on glucose turnover in rats.

@nl

prefLabel

Effects of glucagon-like peptide-I on glucose turnover in rats.

@en

Effects of glucagon-like peptide-I on glucose turnover in rats.

@nl

P1476

Effects of glucagon-like peptide-I on glucose turnover in rats.

@en

P2093

A B Steffens

http://www.w3.org/2001/XMLSchema#string

G Van Dijk

http://www.w3.org/2001/XMLSchema#string

S Lindskog

http://www.w3.org/2001/XMLSchema#string

P2860

Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans.

Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus

Glucagon-like peptide-1(7-36) amide is a new incretin/enterogastrone candidate.

The contribution of the autonomic nervous system to changes of glucagon and insulin secretion during hypoglycemic stress.

Hyperglycemia per se (insulin and glucagon withdrawn) can inhibit hepatic glucose production in man.

Glucagon-like peptide-1 7-36: a physiological incretin in man.

Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus.

Effect of truncated glucagon-like peptide-1 [proglucagon-(78-107) amide] on endocrine secretion from pig pancreas, antrum, and nonantral stomach.

Insulinotropic actions of intravenous glucagon-like peptide-1 (GLP-1) [7-36 amide] in the fasting state in healthy subjects.

P304

E1015-21

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPENDO.1996.270.6.E1015

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

6 Pt 1

http://www.w3.org/2001/XMLSchema#string

P478

270

http://www.w3.org/2001/XMLSchema#string

P50

Jens Juul Holst

Bo Ahrén

P577

1996-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8764187

http://www.w3.org/2001/XMLSchema#string

Effects of glucagon-like peptide-I on glucose turnover in rats.

about

P2860

P2860

Effects of glucagon-like peptide-I on glucose turnover in rats.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698